Granulosa Cell Tumor

A neoplasm composed entirely of GRANULOSA CELLS, occurring mostly in the OVARY. In the adult form, it may contain some THECA CELLS. This tumor often produces ESTRADIOL and INHIBIN. The excess estrogen exposure can lead to other malignancies in women and PRECOCIOUS PUBERTY in girls. In rare cases, granulosa cell tumors have been identified in the TESTES.

Also Known As:

Cancer of Granulosa Cells; Granulosa Cell Cancer; Cancer, Granulosa Cell; Cancers, Granulosa Cell; Cell Cancer, Granulosa; Cell Cancers, Granulosa; Cells Cancer, Granulosa; Cells Cancers, Granulosa; Granulosa Cell Cancers; Granulosa Cell Tumors; Granulosa Cells Cancer; Granulosa Cells Cancers; Tumor, Granulosa Cell; Tumors, Granulosa Cell

Neoplasms: 1361496
- Neoplasms by Site: 4
  - Endocrine Gland Neoplasms: 135
    - Ovarian Neoplasms: 40434
      - Granulosa Cell Tumor: 617
- Neoplasms by Histologic Type: 2
  - Gonadal Tissue Neoplasms
    - Sex Cord-Gonadal Stromal Tumors: 237
      - Granulosa Cell Tumor: 617
Urogenital Diseases: 129
- Urogenital Neoplasms: 488
  - Female Genital Neoplasms: 106
    - Ovarian Neoplasms: 40434
      - Granulosa Cell Tumor: 617
- Genital Diseases: 114
  - Female Genital Diseases: 400
    - Adnexal Diseases: 60
      - Ovarian Diseases: 676
        Ovarian Neoplasms: 40434
        Granulosa Cell Tumor: 617
- Female Urogenital Diseases and Pregnancy Complications
  - Female Urogenital Diseases
    - Urogenital Neoplasms: 488
      - Female Genital Neoplasms: 106
        Ovarian Neoplasms: 40434
        Granulosa Cell Tumor: 617
    - Female Genital Diseases: 400
      - Adnexal Diseases: 60
        Ovarian Diseases: 676
        Ovarian Neoplasms: 40434
        Granulosa Cell Tumor: 617
Endocrine System Diseases: 996
- Endocrine Gland Neoplasms: 135
  - Ovarian Neoplasms: 40434
    - Granulosa Cell Tumor: 617
- Gonadal Disorders: 30
  - Ovarian Diseases: 676
    - Ovarian Neoplasms: 40434
      - Granulosa Cell Tumor: 617

Saara Bryk Selected Research

Saara Bryk Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure